Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 198,234 |
|
|||||
| News | - | ||||||
| Day High | 28.77 | Low High |
|||||
| Day Low | 26.32 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cartesian Therapeutics Inc | RNAC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -2.00 | -6.83% | 27.29 | 23:00:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 28.77 | 26.32 | 28.77 | 27.29 | 29.29 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,136 | 198,234 | US$ 27.04 | US$ 5,359,380 | - | 11.665 - 42.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:05:06 | priorref | 500 | US$ 27.29 | USD |
Cartesian Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.41B | 161.95M | - | 26M | -219.71M | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cartesian Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNAC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 33.76 | 37.00 | 26.32 | 31.89 | 71,804 | -6.47 | -19.16% |
| 1 Month | 26.63 | 41.87 | 23.51 | 30.38 | 86,224 | 0.66 | 2.48% |
| 3 Months | 21.201 | 41.87 | 11.665 | 19.70 | 197,037 | 6.09 | 28.72% |
| 6 Months | 21.843 | 41.87 | 11.665 | 20.96 | 483,152 | 5.45 | 24.94% |
| 1 Year | 24.195 | 42.60 | 11.665 | 23.56 | 592,260 | 3.10 | 12.79% |
| 3 Years | 24.195 | 42.60 | 11.665 | 23.56 | 592,260 | 3.10 | 12.79% |
| 5 Years | 24.195 | 42.60 | 11.665 | 23.56 | 592,260 | 3.10 | 12.79% |
Cartesian Therapeutics Description
| Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. |
